Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Change in Accured Expenses (2024 - 2025)

Updated

Niki BioSolutions (NIKI) posted Change in Accured Expenses of $441,538 for FY2025.

Analysis

Niki BioSolutions (NIKI) Change in Accured Expenses (2024 - 2025) Analysis & Trends

Since FY2017, Niki BioSolutions has reported Change in Accured Expenses for 9 years.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of -11.2% (FY2020 to FY2025).
  • The FY2025 figure stands as the highest annual Change in Accured Expenses since FY2022.
  • Business Quant data shows NIKI's Change in Accured Expenses at -$422,705 in FY2024, $398,635 in FY2023 (-79.2%), $1.92 million in FY2022 (+124.3%) and $855,272 in FY2021 (+6.8%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Niki BioSolutions 2.51 Mn 2.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 365,238.00
Nov 30, 2024 -81,670.00
Aug 31, 2024 94,611.00
API Access

Niki BioSolutions Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NIKI&period=max&api_key=YOUR_API_KEY